Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.48 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MC4R | P32245 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | MC3R | P41968 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL279723 | 0.81 | FAAH (0.48) | FAAHCES1ADORA3TSHRMC4R | |
| SCHEMBL1704958 | 0.71 | — | — | |
| Hydrochloric Acid SCHEMBL29156127 | 0.69 | FAAH (0.49) | FAAHCES1ADORA3TSHRMC4R | |
| SCHEMBL758594 | 0.69 | — | — | |
| SCHEMBL15123017 | 0.69 | — | — | |
| SCHEMBL29757846 | 0.69 | KMT2A (0.41) | FAAHCES1ADORA3TSHRMC4R | |
| SCHEMBL21177772 | 0.69 | FAAH (0.39) | FAAHCES1ADORA3TSHRMC4R | |
| SCHEMBL21177286 | 0.67 | NOTUM (0.42) | FAAHCES1ADORA3TSHRMC4R | |
| SCHEMBL31453785 | 0.66 | PIK3CA (0.40) | FAAHCES1KMT2A | |
| SCHEMBL24714108 | 0.65 | PIK3CG (0.38) | FAAHCES1ADORA3TSHRMC4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019142053-A2 | THERAPEUTIC INHIBITORY COMPOUNDS | LIFESCI PHARMACEUTICALS, INC. (BB) | 2019-07-25 | — | — | WO | claimed |
| WO-2019142053-A2 | THERAPEUTIC INHIBITORY COMPOUNDS | LIFESCI PHARMACEUTICALS, INC. (BB) | 2019-07-25 | — | — | WO | disclosed |